NC
Nexthera Capital Portfolio holdings
AUM
$120M
1-Year Return
20.18%
This Quarter Return
-9.25%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$153M
AUM Growth
+$25.2M
(+20%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
21.26%
Top 10 Holdings %
Top 10 Hldgs %
70.63%
Holding
52
New
17
Increased
3
Reduced
8
Closed
14
Top Buys
| 1 |
Novartis
NVS
|
$14.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$14.1M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
SHPG
Shire pic
SHPG
|
$10.7M |
| 5 |
AstraZeneca
AZN
|
$8.2M |
Top Sells
| 1 |
GSK
GSK
|
$14.9M |
| 2 |
Pfizer
PFE
|
$10.9M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.02M |
| 4 |
Neurogene
NGNE
|
$4.54M |
| 5 |
LCI
Lannett Company, Inc.
LCI
|
$4.44M |
Sector Composition
| 1 | Healthcare | 92.1% |